Cover Image

Myeloid cells which secrete S100 proteins in juvenile dermatomyositis may contribute to disease activity

Saved in:

Bibliographic Details
Main Authors:	Varsani H (Author), Wittkowski H (Author), Roth J (Author), Holton J (Author), Wedderburn LR (Author)
Format:	Book
Published:	BMC, 2008-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gastroparesis associated with Juvenile Dermatomyositis
by: Martin N, et al.
Published: (2008)

Being on the juvenile dermatomyositis rollercoaster: a qualitative study
by: Polly Livermore, et al.
Published: (2019)

The Vasculopathy of Juvenile Dermatomyositis
by: Charalampia Papadopoulou, et al.
Published: (2018)

JUVENILE DERMATOMYOSITIS
by: Sigrid Covaci, et al.
Published: (2016)

Juvenile Dermatomyositis with Generalized Edema
by: J Gordon Millichap
Published: (2001)

CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
by: van Royen- Kerkhof Annet, et al.
Published: (2011)

CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
by: van Royen-Kerkhof Annet, et al.
Published: (2011)

Comparison of data from the juvenile dermatomyositis national (UK & Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies with a survey of current practice throughout the UK and Ireland
by: Beard L, et al.
Published: (2011)

Respiratory involvement in juvenile dermatomyositis
by: Fabi M, et al.
Published: (2008)

Juvenile Dermatomyositis in Pregnancy
by: Anthony Emeka Madu, et al.
Published: (2013)

Juvenile dermatomyositis in Western Switzerland
by: Hofer M, et al.
Published: (2011)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
by: Bilginer Y, et al.
Published: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
by: Viana VST, et al.
Published: (2011)

Juvenile dermatomyositis (JDM) sine myositis
by: Schulz A, et al.
Published: (2011)

Treatment and Clinical Outcome of Juvenile Dermatomyositis
by: Chih-Hsing Hung
Published: (2015)

Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients
by: González MA, et al.
Published: (2011)

Cardiac findings in children with juvenile Dermatomyositis at disease presentation
by: Serdar Cantez, et al.
Published: (2017)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
by: Hirani SP, et al.
Published: (2008)

Favorable outcomes with reduced steroid use in juvenile dermatomyositis
by: Amir B. Orandi, et al.
Published: (2021)

Atypical presentation of anti-NXP-2 positive juvenile dermatomyositis
by: Andreia Coimbra-Sousa, et al.
Published: (2023)

Juvenile Dermatomyositis Early Onset, Case Report
by: Cagdas Boyvadoglu, et al.
Published: (2024)

Axillary Skin Ulcers in Infants with Juvenile Dermatomyositis
by: Hiroyuki Wakiguchi, et al.
Published: (2017)

Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
by: Aviya Lanis, et al.
Published: (2022)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
by: Luz Contreras, et al.
Published: (2011)

The PRINTO provisional definition of remission in juvenile dermatomyositis
by: Kasapcopur O, et al.
Published: (2011)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
by: Emeryk Andrzej, et al.
Published: (2011)

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
by: Livermore P, et al.
Published: (2008)

Body mass index at diagnosis affects disease course in juvenile dermatomyositis
by: Patwardhan Anjali, et al.
Published: (2012)

Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017)

Cutaneous Manifestations of Juvenile Dermatomyositis: A Case Series
by: Sunanda Arun Mahajan, et al.
Published: (2021)

Juvenile dermatomyositis, clinical manifestations and outcome in an Iranian cohort
by: Massoud Saghafi, et al.
Published: (2014)

Evaluation of dystrophic calcification in juvenile dermatomyositis and systemic sclerosis
by: Marimar Saez-de Ocariz
Published: (2014)

A rare case of juvenile dermatomyositis and review of literature
by: Anjali T Bharani, et al.
Published: (2017)

Evaluation of dystrophic calcinosis in juvenile dermatomyositis and systemic sclerosis
by: Saéz Ocariz Marimar, et al.
Published: (2014)

Juvenile dermatomyositis associated to lymphoepithelioma, a nasopharyngeal carcinoma
by: França CT, et al.
Published: (2011)

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)
by: Rabheh Abdul-Aziz, et al.
Published: (2017)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
by: Patrick F, et al.
Published: (2011)

Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective
by: C. Boros, et al.
Published: (2022)

The Damage Associated Molecular Pattern (DAMP) molecule S100A12 induces pro-inflammatory responses in monocytes via innate immunity signalling pathways
by: Wittkowski H, et al.
Published: (2008)

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)
by: Wittkowski H, et al.
Published: (2008)